EBACW (European Biotech Acquisition) OCF Margin %: 0.00% (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EBACW European Biotech Acquisition Corp EBACW
22 GF Score
Price $0.52
View Full Analysis

What is European Biotech Acquisition OCF Margin %?

European Biotech Acquisition EBACW 22 OCF Margin % is 0.00% as of Dec. 2022. GuruFocus rates EBACW with a GF Score™ of 22/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. European Biotech Acquisition's Cash Flow from Operations for the three months ended in Dec. 2022 was $0.08 Mil. European Biotech Acquisition's Revenue for the three months ended in Dec. 2022 was $0.00 Mil. Therefore, European Biotech Acquisition's OCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

As of today, European Biotech Acquisition's current OCF Yield % is 0.00%.

The historical rank and industry rank for European Biotech Acquisition's OCF Margin % or its related term are showing as below:


EBACW's OCF Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -0.75
* Ranked among companies with meaningful OCF Margin % only.

European Biotech Acquisition OCF Margin % Related Terms

European Biotech Acquisition OCF Margin % Historical Data

* Premium members only.

The historical data trend for European Biotech Acquisition's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Biotech Acquisition OCF Margin % Chart

European Biotech Acquisition Annual Data
Trend Dec21 Dec22
OCF Margin %
0.00 0.00

European Biotech Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
EBACW
22GF Score
European Biotech Acquisition Corp EBACW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Biotech Acquisition OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

European Biotech Acquisition's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-0.515/0
= %

European Biotech Acquisition's OCF Margin for the quarter that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=0.081/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
European Biotech Acquisition (EBACW) has a OCF Margin % of 0.00% as of Dec. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on European Biotech Acquisition and its competitors.
Is European Biotech Acquisition's OCF Margin % too high?
European Biotech Acquisition's current OCF Margin % is 0.00%. Overall, European Biotech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does European Biotech Acquisition's OCF Margin % compare to CNTQ and LION?
European Biotech Acquisition's OCF Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Diversified Financial Services company?
A good OCF Margin % depends on the Diversified Financial Services industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on European Biotech Acquisition and its competitors. European Biotech Acquisition's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Biotech Acquisition stock overvalued right now?
European Biotech Acquisition (EBACW) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. European Biotech Acquisition's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For European Biotech Acquisition (EBACW), the current OCF Margin % is 0.00% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

European Biotech Acquisition Business Description

Address EPFL Innovation Park Building, Lausanne, CHE, 1015
European Biotech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for EBACW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price